BCAS2 anticorps (C-Term)
Aperçu rapide pour BCAS2 anticorps (C-Term) (ABIN1976962)
Antigène
Voir toutes BCAS2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 175-225, C-Term
-
Specificité
- Region between residue 175 and the C-terminus (residue 225) of human Breast Cancer Amplified Sequence 2 using the numbering given in entry NP_005863.1 (GeneID 10286).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IF (1:1000 - 1:10000), IHC, IHC-P (1:2000 - 1:10000), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Anaplastic Thyroid Carcinoma, Breast Carcinoma, Laryngeal Squamous Cell Carcinoma, Ovarian Carcinoma, Pancreatic Islet Cell Tumor, Prostate Carcinoma, Small Cell Lung Cancer. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
-
Autre désignation
- BCAS2
-
Sujet
-
Name/Gene ID: BCAS2
Synonyms: BCAS2, Pre-mRNA-splicing factor SPF27, SPF27, Snt309, DAM1 -
ID gène
- 10286
Antigène
-